VIP and Achalasia: Decreased levels of the nitric oxide synthase (NOS) and vasoactive intestinal polypeptide (VIP) as inhibitory neurotransmitters in the myenteric plexus disrupt esophageal neuromuscular function in the patients with achalasia (Ates and Vaezi, 2015).